The ubiquitin proteasome system (UPS) consists of a cascade of enzymatic reactions leading to the ubiquitination of proteins, with consequent degradation or altered functions of the proteins. Alterations in UPS genes have been associated with male infertility, suggesting the role of UPS in spermatogenesis. In the present study, we questioned whether UPS is involved in extensive remodeling and functional changes occurring during the differentiation of neonatal testicular gonocytes to spermatogonia, a step critical for the establishment of the spermatogonial stem cell population. We found that addition of the proteasome inhibitor lactacystin to isolated gonocytes inhibited their retinoic acid-induced differentiation in a dose-dependent manner, blocking the induction of the spermatogonial gene markers Stra8 and Dazl. We then compared the UPS gene expression profiles of Postnatal Day (PND) 3 gonocytes and PND8 spermatogonia, using gene expression arrays and quantitative real-time PCR analyses. We identified 205 UPS genes, including 91 genes expressed at relatively high levels. From those, 28 genes were differentially expressed between gonocytes and spermatogonia. While ubiquitin-activating enzymes and ligases showed higher expression in gonocytes, most ubiquitin conjugating and deubiquitinating enzymes were expressed at higher levels in spermatogonia. Concomitant with the induction of spermatogonial gene markers, retinoic acid altered the expression of many UPS genes, suggesting that the UPS is remodeled during gonocyte differentiation. In conclusion, these studies identified novel ubiquitin-related genes in gonocytes and spermatogonia and revealed that proteasome function is involved in gonocyte differentiation. Considering the multiple roles of the UPS, it will be important to determine which UPS genes direct substrates to the proteasome and which are involved in proteasome-independent functions in gonocytes and to identify their target proteins.
INTRODUCTION
The ubiquitin proteasome system (UPS) is the main pathway by which proteins are degraded in eukaryotes, occurring through the ligation of ubiquitin peptides to the target proteins [1] [2] [3] . Ubiquitination has also been implicated in nonproteolytic functions such as the regulation of protein interactions, signal transduction, kinase activation, DNA repair, endocytosis, protein trafficking, cell cycle progression [1] [2] [3] [4] , intercellular communication [5] , cell proliferation [6] , and apoptosis [7] . Consistent with its many functions, alterations of the UPS have been implicated in many pathological processes including neurological and immune disorders, cancer [1] [2] [3] [4] 8] , diabetes and obesity [9] , and infertility [10] [11] [12] [13] . Multiple enzymatic reactions are involved in the attachment of a monoubiquitin or polyubiquitin chain to a substrate protein, including an E1-activating enzyme, an E2 conjugating enzyme, and an E3 ligase [3, 4] . This is a complex process in which the E1-activating enzyme activates the ubiquitin molecule which is then transferred to a specific residue of the E2 conjugating enzyme and finally to an E3 ligase that will attach the ubiquitin tag onto its specific substrate. The 26S proteasome complex will then recognize and degrade the ubiquitinated substrate. The UPS also consists of deubiquitinating enzymes that can act antagonistically to the ubiquitination process [14] [15] [16] .
Spermatogenesis relies on the existence of a pool of germline stem cells, the spermatogonial stem cells (SSCs) , that will support the production of mature spermatozoa throughout the lifetime of a male [17, 18] . Precursors of these SSCs are termed gonocytes (also called pre-or prospermatogonia) [19] . Gonocyte development relies on the occurrence of timed events, including phases of quiescence, proliferation, migration within the seminiferous cords, differentiation, and apoptosis, taking place between the fetal and neonatal periods [19] . These processes are associated with major reorganization of the cell structure, changes in the responsiveness to Sertoli cell-secreted factors, and intracellular signaling pathways, some of which we unveiled in earlier studies [19] [20] [21] [22] [23] . The plasticity of these cells is clearly illustrated by their ability to proliferate in response to a combination of PDGF and estradiol at Postnatal Day 3 (PND3) but not at PND2 (20) and the down-regulation of PDGF receptors and up-regulation of c-KIT expression as the gonocytes progress in their development [22] [23] [24] . Similarly, gonocyte differentiation, which occurs in a precisely timed manner under the control of retinoic acid [22] , also requires the cell to migrate and make contact with the basement membrane of the seminiferous cord [19] , implying major changes in the behavior and signaling profile of these cells. Disruption of gonocyte differentiation is believed to be at the origin of testicular cancer, the most common cancer in young men [25] , and can also lead to infertility, underlining the importance of understanding these early phases of germ cell development. We have shown in previous studies that both ubiquitination and deubiquitination play a role in later phases of spermatogenesis [26] [27] [28] [29] . These studies were carried out in PND10-PND65 mice, ages that encompass all types of spermatogonia, from the undifferentiated type A single to the final differentiated type B spermatogonia [17] . While knocking down the E2 conjugating enzyme UBC4 resulted in mice with delayed spermatogenic cycle [27] , those lacking the deubiquitinating enzyme USP2 presented abnormal spermatozoa motility and a severe defect in fertilization [12] . More recently, mice lacking the polyubiquitin B gene were found to be infertile and to present multiple testicular gene expression alterations, illustrating the complexity of UPS involvement in testicular germ cell development [30] .
In view of the extended phenotypic and functional changes taking place during gonocyte differentiation, we hypothesized that UPS proteins might be involved in this process. To this end, we examined the effects of a proteasome inhibitor on retinoic acid-induced gonocyte differentiation. Because UPS genes had not been studied in gonocytes before, we also determined which UPS genes were expressed in PND3 rat gonocytes in comparison to PND8 spermatogonia, using gene expression array and quantitative real-time PCR (qPCR). Further clarification of the role of these genes in gonocyte differentiation and the identification of the signaling pathways regulated by UPS should bring new light to the mechanisms underlying SSC formation and provide novel candidate molecules with which to study testicular cancer and infertility.
MATERIALS AND METHODS

Animals
Newborn male Sprague Dawley rats were purchased from Charles River Laboratories (Saint-Constant, QC, Canada). PND3 and PND 8 pups were euthanized and handled according to protocols approved by the McGill University Health Centre Animal Care Committee and the Canadian Council on Animal Care.
Cell Isolation
Gonocytes were isolated from PND3 rat testes using 30-40 pups per preparation as previously described [20] [21] [22] [23] 31] . In summary, decapsulated testes were submitted to sequential enzymatic tissue dissociation, filtration, and differential plating overnight in 5% fetal bovine serum (FBS) (Invitrogen, Burlington, ON, CA) to allow for somatic cell adhesion. The next morning, nonadherent cells were further separated on a 2%-4% bovine serum albumin (BSA) (Roche Diagnostics, Indianapolis, IN) gradient in the absence of serum.
Fractions that contained the most gonocytes (as judged by their morphology and large size) were chosen and pooled to obtain final cell suspensions presenting 80%-90% purity or above 95% purity for preparations used in gene array analysis. After centrifugation, the cells were either directly frozen for later RNA or protein extraction, or collected on microscopic slides by cytospin centrifugation, or kept for 1 day in culture. Spermatogonia were isolated from PND8 rat testes using 10-20 pups per preparation. The method used for spermatogonia cell isolation was exactly that used for PND3 gonocytes described above [22] . Enriched spermatogonia were either stored at À808C until further processing or collected by cytospin centrifugation. All experiments were performed on three to four independent gonocyte or spermatogonia preparations. Enriched Sertoli cell preparations that contained ;20% myoid cells were also collected during the process of cell isolation at PND3 or PND8. These cells were used as a comparison for gene and protein analysis.
Gonocyte Cultures
Isolated gonocytes were cultured for 1 day to examine the effects of alltrans retinoic acid (RA) (Sigma-Aldrich, Oakville, ON, Canada) as previously described [22] , or the proteasome inhibitor lactacystin (Sigma-Aldrich). Gonocytes from the final BSA pool (with a purity of ;80%-90%) were resuspended in RPMI 1640 medium (Invitrogen) supplemented with 2.5% FBS (Invitrogen), 2% penicillin/streptomycin (CellGro; Mediatech, Manassas, VA), and 1% amphotericin B (CellGro). Gonocytes were then plated in 24-well plates at a density of 10,000 cells in a 500-ll final volume containing medium alone or RA (1 lM; stock solution in ethanol) and/or the proteasome inhibitor lactacystin (stock solution in ethanol; Sigma-Aldrich) at 0.1, 0.5, or 1.0 lM. In some experiments, we also tested the effects of the proteasome inhibitor bortezomib (Velcade; product no. PS-341; stock solution in dimethyl sulfoxide [DMSO] ; Selleck Chemicals, Houston, TX) at 5, 10, 25, and 50 nM. Some experiments were performed to determine whether the solvents used to prepare the stock solutions of RA and the two proteasome inhibitors affected the transcripts levels in control cells by measuring mRNA expression levels of representative genes, including Stra8, Dazl, tubulin, Gapdh, and Huwe1. Combinations of 0.1%À1% ethanol with or without 0.0025%-0.5% DMSO were used to reproduce the final solvent levels present in treated samples and were compared to samples with medium alone. These experiments showed that the presence of the two solvents, alone or in combination, did not affect the basal mRNA levels of any of the genes examined (data not shown). Thus, using these samples or medium alone as a control to calculate the fold changes in treated samples did not make a difference in the results. Because of the limited numbers of gonocytes per experiment and the lack of effect of the solvents compared to medium alone, control samples consisting of medium alone were used in subsequent experiments. The cells were incubated for 1 day in a 3.5% CO 2 incubator at 378C. At the end of the incubation period, the cells were pelleted, and their RNA was extracted for qPCR analysis. Each condition was tested in duplicate wells, and at least three independent experiments were performed for each condition examined.
RNA Extraction and RT-PCR Analysis
Total RNA was extracted from cell pellets using the PicoPure RNA isolation kit (Arcturus, Mountain View, CA) and digested with DNase I Table 1 . The reactions were carried out using Platinum Taq DNA polymerase and amplified using the iCycler thermal cycler (Bio-Rad; Hercules, CA). PCR cycle conditions were 948C for 3 min; then 40 cycles of 948C for 30 sec at 508C-608C (depending on primer set) for 30 sec, and 728C for 30 sec; followed by a 5-min extension at 728C. PCR products were then separated on a 2% agarose gel. Simultaneous runs of the samples were performed using 18S primers as a housekeeping gene.
Gene Expression Array Analysis
Illumina microarray analysis was done by the McGill University's Genome Quebec facility with RNA samples extracted from isolated PND3 gonocytes and PND 8 spermatogonia preparations, as well as their corresponding Sertoli/ myoid cell fractions. Three independent RNA extracts of PND3 gonocytes and PND8 spermatogonia and two independent preparations of corresponding Sertoli/myoid cells were processed for gene array analysis. In order to get sufficient amounts (100 ng/ll) of RNA per sample, each gonocyte RNA sample was prepared from a total of 60-90 pups, while each spermatogonial RNA was isolated from 10 PND8 pups. Moreover, only the highest purity fractions from the BSA gradients were used in these studies to ensure more than 95% purity in the gonocytes and spermatogonia cell preparations. After we validated the RNA quality and purity, the samples were analyzed using the RatRef-12 Expression BeadChip for genome-wide expression analysis, which contains 22 523 probes selected primarily from the NCBI RefSeq database. Data analysis was performed by Dr. Jaroslav Novak [32] and contained quality control analysis, normalization, abbreviation, and dispersion analysis, differential analysis of gene expression, and gene set enrichment analysis. Data were normalized using quantile normalization, corrected for the background signal, and abbreviated by eliminating the low-expression-end of the spectrum. Abridgement of data reduced the tables to 19 100 from the original 22 523 genes and expressed sequences. The comparisons between PND3 gonocytes and PND8 spermatogonia were done using the Bayesian approach, which emphasizes the significance of variation between replicates of the same sample rather than excluding genes according to a ''fold-change'' approach. However, a cutoff was applied in the selection of UPS genes for which the comparisons were made. In order to determine an appropriate cut-off value to use, we determined the proportion of genes represented in various ranges of signal intensities on the arrays. We found that the majority (65%) of all genes on the arrays had a relative signal intensity of 20, while 23% of the genes had an intensity of !50, 10% had !300, and only 1% had !2000. Thus, a cutoff of 50 appeared reasonable and was used to select the genes to study further.
Real-Time Quantitative PCR (qPCR)
qPCR was performed with a LightCycler 480 using a SYBR Green PCR Master Mix kit (Roche Diagnostics) and primers specific for the genes of interest, designed either with the DLUX program from Invitrogen or the Roche primer design software ( Table 2 ). The cycling conditions consisted of an initial step at 958C, followed by 45 cycles at 958C for 10 sec, 618C for 10 sec, and 728C for 10 sec. This was followed by melting curves and cooling cycles. The comparative threshold cycle (Ct) method was used to analyze the data. The amounts of the various genes were normalized to the endogenous reference (18S rRNA) by calculating the value of 2 DCt , with DCt being the difference between the threshold cycle point (Ct/Cp) of the gene of interest and that of 18S rRNA. Data obtained for 18S rRNA showed that it presented no or minimal changes in Cp values between samples. Because stimulatory agents and culture conditions can alter the expression of genes otherwise considered ''housekeeping,'' we initially determined the Cp values of four potential housekeeping genes, Gapdh, Tubulin, b-Actin and 18S rRNA, as well as the Cp values for two UPS genes, Ubc2 and Ubc4, in cDNA samples from isolated gonocytes cultured for 1 day with medium with or without RA. We compared the data obtained for Ubc2 and Ubc4 by using housekeeping genes to the values obtained using cDNA standard curves established for each primer set, in which the template was a mixture of the cDNAs analyzed. This approach showed that 18S rRNA was very constant, with less than half a cycle variation between control and RA-treated samples, and that using it for normalization provided Ubc2 and Ubc4 data consistent with those obtained using the standard curves. Interestingly, RA treatment consistently decreased the expression of Tubulin by 35% (n ¼ 9; P , 0.01), Gapdh by 37% (n ¼ 9; P , 0.01), and b-Actin by 67% (n ¼ 3; P , 0.001) over several experiments, whereas other agents added to gonocyte cultures did not have such effects (data not shown). Thus, 18S rRNA was used for all experiments as the reference for data normalization.
We also determined the primer efficiency for 8 of the primer sets used in qPCR analyses, including the 18S reference and genes that showed significant differences in expression between conditions as well as genes for which qPCR and gene array data either fitted well or diverged. For each primer set, qPCR reactions were carried out using serial dilutions of rat genomic testis DNA used as template. The resulting cycle numbers were plotted in log scale against DNA amounts, and the slope values were used to calculate primer efficiency (optimal efficiency ¼ 2; ideal slope ¼ À3.32), using the formula: primer efficiency ¼ 10 (À1/slope) . These experiments confirmed that 6 primer sets, including the 18S reference, had close to 100% efficiency, validating the qPCR results and the comparison of the relative abundances of these genes. The 2 primer sets that had low efficiency were those of genes presenting lower transcript levels in qPCR than expected from the gene array data, providing an explanation to the observed discrepancies.
The final data were expressed in arbitrary units representing the mRNA levels of the genes of interest present in the samples tested. Assays were performed in triplicate. For each treatment condition or cell type studied, the mRNA levels were determined in samples from three to four independent cell preparations. Results were expressed as means 6 SEM of the fold changes in relative expression levels normalized to those of 18S rRNA between either gonocytes and spermatogonia or control and RA-treated gonocytes in culture.
Immunoblot Analysis
Aliquots of cell preparations were solubilized in Laemmli buffer, and proteins were separated on 4%-20% Tris-glycine gels (Invitrogen). The gels were then transferred to a polyvinylidene fluoride membranes (Bio-Rad). After blocking with 5% milk in 13 Tween 20-Tris-buffered saline (TTBS), the membranes were incubated with specific primary antibodies diluted in TTBS overnight at 48C (see Table 3 ), followed by incubation with a horseradish peroxidase-coupled secondary antibody (goat anti-rabbit; 1:1500 dilution; Cell Signaling) for 1 h and then with ECL-enhanced chemiluminescence (GE Healthcare). Images were captured using the LAS-4000 gel documentation system (Fujifilm). Some membranes were first treated with rabbit immuno- 
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globulin G (IgG) instead of a primary antibody to determine nonspecific bands and showed no signal. Each membrane was repeatedly processed with primary antibodies and stripped 3-4 times, using Restore Plus Western blot stripping buffer (Thermo Scientific). Tubulin was used as loading reference.
Immunocytochemistry
Protein expression of seven ubiquitin-related genes was examined by immunocytochemistry, following a previously described protocol [21, 31] . Briefly, gonocytes (or spermatogonia) were collected right after BSA gradient separation, washed with PBS, fixed with 4% paraformaldehyde in PBS for 5 min, centrifuged, washed, and then collected onto microscopic slides by cytospin centrifugation. The slides were dried and treated with a mixture of acetone/methanol (60/40), followed by DakoCytomation target retrieval solution (Dako North America Inc., Carpinteria, CA). The slides were incubated overnight at 48C with various primary antibodies ( Table 3) . The next day, the slides were treated for colorimetric staining using biotin-coupled secondary antibodies (BD Pharmingen, Mississauga, ON, CA) and streptavidin-coupled horseradish-peroxidase (HRP)/colorimetric HRP chromogen (AEC; Invitrogen), further counterstained with hematoxylin (Invitrogen), and cover-slipped. Negative controls were produced by incubating some samples with nonspecific rabbit IgG (Invitrogen). Representative results are shown.
Immunohistochemistry
Testes were fixed in 3.5% buffered formaldehyde, embedded in paraffin, and treated for immunohistochemical analysis as previously described [33] . Briefly, 5-lm sections were dewaxed, rehydrated, and treated for antigen retrieval with DAKO and processed for immunostaining using primary antibody incubation overnight at 48C, followed by secondary antibodies, HRP/colorimetric HRP chromogen (AEC) and hematoxylin counterstaining as described above. Nonspecific IgG was used as negative control. Representative results are shown.
Statistical Analysis
Statistical analysis was performed using unpaired two-tailed t-test with statistical analysis functions in GraphPad Prism version 5.0 software (GraphPad Inc., San Diego, CA) or one-way ANOVA with a Bonferroni correction. All experiments were performed three to four times independently, and P values less than 0.05 were considered statistically significant.
RESULTS
Proteasome Activity Is Required for Gonocyte Differentiation
We have previously shown that the differentiation of neonatal gonocytes can be studied in vitro by measuring increases in the expression of genes characteristic of differentiating spermatogonia in gonocytes incubated with RA [22] . As shown in Figure 1A , the addition of 1 lM RA to gonocytes induced nearly 6-fold increase in the mRNA expression of the stimulated by retinoic acid 8 (Stra8) gene, a marker of differentiating spermatogonia involved in cell progression toward meiosis [34] [35] [36] . Similarly, the mRNA expression of the deleted in azoospermia-like (Dazl) gene product, an RNA binding protein found to increase in differentiating spermatogonia [37] , increased by 50% upon RA treatment (Fig. 1B) . However, addition of the nonreversible natural proteasome inhibitor lactacystin [38, 39] significantly inhibited in a dosedependent manner the effects of RA on both genes, with greater than 80% suppression at the highest concentrations. While lactacystin alone had no effect on the basal expression of Stra8 (Fig. 1 ) and several genes, including UPS and housekeeping genes (see Supplemental Figure S1 ; all Supplemental Data are available online at www.biolreprod.org), it induced a significant decrease in the basal levels of Dazl transcripts. We also examined the effects of bortezomib, another proteasome inhibitor [39] , and found that it had inhibitory effects on Stra8 and Dazl induction by RA similar to those of lactacystin, except that the inhibition was less pronounced on Stra8 (data not shown). These results showed that gonocyte differentiation requires an active proteasome.
Protein Expression Profiles in PND3 Gonocytes and PND8 Spermatogonia of UPS Genes Previously Identified in Juvenile and Adult Testicular Germ Cells
In search of genes potentially involved in gonocyte proteasome activity, we examined whether UPS genes previ-FIG. 1. Effect of the proteasome inhibitor lactacystin on in vitro gonocyte differentiation. Isolated PND3 gonocytes were induced to differentiate in vitro by the addition of 1 lM RA to the medium containing 2.5% FBS for 1 day. Gonocyte differentiation was determined by measuring the mRNA expression of Stra8 and Dazl, two genes markers of spermatogonial differentiation, by qPCR analysis. The role of the proteasome in this process was evaluated by adding the proteasome inhibitor lactacystin at concentrations of 0.1, 0.5, and 1 lM, alone or with RA. The addition of lactacystin inhibited in a dose-dependent manner the effects of RA on gonocyte differentiation. The results means 6 SEM of 3 independent experiments per treatment, with each sample performed in duplicate wells. *P , 0.05; **P , 0.01; ***P , 0.001.
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FIG. 2.
Messenger RNA and protein expression in PND3 gonocytes and PND8 spermatogonia of UPS genes previously identified in juvenile and adult testes. The mRNA (A) and protein (B-D) expression of seven UPS genes, including two E2 ubiquitin conjugating enzymes (UBC2, UBC4), two E3 ubiquitin ligases (UBR5, HUWE1), two deubiquitinating enzymes (USP2, USP19), and ubiquitin, were examined in isolated cells (A-C) and testes sections (D). A) RT-PCR analysis of the mRNA expression of UPS genes in PND3 gonocytes (G3) compared to their expression in PND3 Sertoli/myoid cells (S/M3) showed that the 7 genes were expressed in germ and somatic cells at PND3. B) protein expression was evaluated by immunoblot analysis and showed the presence of bands of the expected sizes in gonocytes. Lad, ladder; arrows indicate expected size of proteins. C) Freshly isolated gonocytes and spermatogonia were collected on microscopic slides by cytospin centrifugation and immunostained for the indicated proteins. Bar ¼ 20 lm. Representative pictures are shown. D) protein expression was evaluated by immunohistochemistry on sections from PND3 and PND8 testes. Background signal was determined by using rabbit IgG instead of primary antibody on some slides. Arrows indicate areas of the germ cells in contact with the tubules' basement membrane.
ously found in spermatogonia to spermatids were already expressed in germ cells prior to spermatogonia formation. The mRNA and protein expression levels of seven UPS genes were measured in PND3 gonocytes and the corresponding Sertoli/ myoid and interstitial cells. They included the E2 ubiquitin conjugating enzymes UBC2 (UBC2E; E217kB) and UBC4, the ubiquitin ligases UBR5 (EDD) and HUWE1 (LASU1, E3 histone , MULE, ARFBP1, HectH9), ubiquitin and the deubiquitinating enzymes USP19 and USP2 (UBP-testis/UBP41), which include two variants, the USP2a/UBP69 long isoform (Ubp-t2.Ubpa; 69 kDa) and the short isoform Usp2b/UBP45 (Ubp-t1, Ubpb; 45 kDa). As shown in Figure 2A , mRNAs for all seven genes were present in testicular germ and somatic cells at PND3.
Immunoblot analysis showed that the corresponding proteins were all expressed in gonocytes (Fig. 2B) . The immunoreactive bands were positioned at the expected size and presented signal indicative of high levels for UBC2, HUWE1, UBR5 and ubiquitin mono-, di-, and trimers, as a diffuse band for USP19, and at low levels for UBC4 and the 69-kDa form of USP2. The two UBR5 and USP19 proteins were present in gonocytes but not detected in Sertoli/myoid cells, while gonocytes did not seem to express the short 45-kDa USP2 isoform, which was visible in somatic cells (Fig. 2B) .
Protein levels were also examined by immunocytochemical analysis of paraformaldehyde-fixed isolated PND3 gonocytes and PND8 spermatogonia (Fig. 2C) . UBC2, UBC4, HUWE1, and ubiquitin were strongly expressed in the cytoplasm of gonocytes. USP2 immunoreactivity was weak but was consistently found in the nucleus of gonocytes, while it localized to the cytoplasm in spermatogonia. In these experiments, one could not detect UBR5 immunoreactivity in gonocytes, although a positive signal was found in isolated spermatogonia. USP19 expression was very low at both ages, below detection levels in gonocytes and as a faint cytoplasmic staining in spermatogonia. In contrast, the other UPS proteins showed a strong immunoreactivity in spermatogonia, with UBC4, HUWE1, and ubiquitin present mainly in nuclei (Fig. 2C) .
Immunohistological analysis of the proteins in tissue sections confirmed that PND3 and PND8 germ cells expressed the seven UPS proteins in vivo, which appeared more abundant in germ cells than in the surrounding somatic cells (Fig. 2D) . Indeed, USP19 and UBR5 protein expression were detected only in gonocytes, in agreement with the immunoblot data, and despite the presence of transcripts in the somatic cells ( Fig. 2A  and D) . Both proteins also appeared preferentially expressed in germ cells at PND8. Interestingly, UBR5, HUWE1, USP2, and ubiquitin were strongly expressed in the cytoplasmic areas where germ cells had established contact with the basement membrane of the seminiferous tubules (Fig. 2, arrows) . Noticeably, at PND8, many germ cells had reached the basement membrane but presented an intermediate elongated phenotype, indicating that they had not yet established full alignment with the basement membrane nor achieved full differentiation to spermatogonia.
Gene Expression Array Analysis of UPS Genes in Gonocytes, Spermatogonia, and Sertoli/Myoid Cells To determine thoroughly the UPS gene profile of gonocytes, we performed gene expression array analyses of several PND3 gonocytes preparations and compared them to those of PND8 spermatogonial preparations, using a rat Illumina gene expression platform. Gene expression arrays were also performed with PND3 and PND8 Sertoli and myoid cell mixtures isolated during the cell isolation procedure, as a way to better identify potential germ cell-specific UPS genes. A global comparison of the gene expression profiles obtained for germ cells and Sertoli/myoid cells by using principal component analysis showed very different profiles for the somatic and germ cells, confirming the efficient enrichment of the germ cells (see Supplemental Fig. S2 ). Of the 19 100 genes and expressed sequences validated on the arrays, we identified 205 that were related to the ubiquitin system. Among those, 191 were UPS enzymes and 14 were either donors of ubiquitin moieties, proteins interacting with ubiquitin enzymes, or scaffolding proteins (see Supplemental Table S1 ). Most of the UPS genes expressed in germ cells were E3 ubiquitin ligases, followed by deubiquitinating enzymes. However, approximately half of these genes were expressed at low levels, presenting signal intensities below 50. Applying a cutoff intensity of 50 led to the selection of 91 UPS genes for which the fold changes in transcript levels among gonocytes, spermatogonia, and Sertoli/myoid cells were calculated (Table  4 ). Among these highly expressed transcripts, the most abundant UPS transcripts in germ cells were those of E3 ubiquitin ligases, representing 55% of the genes, followed by the deubiquitinating enzymes (DUBs) (21%), E2 ubiquitin conjugating enzymes (13%), other UPS-related genes (9%) and only 2% were E1 activating enzymes (Fig. 3A) .
The polyubiquitin gene Ubb and the ubiquitin A-52 residue ribosomal protein fusion product 1 (Uba52), ubiquitin-like protein neural precursor cell expressed developmentally downregulated 8 (Nedd8), and ubiquilin 1 (Ubqln1) genes were highly expressed (signals above 700) and had the most abundant UPS-related mRNAs in both gonocytes and spermatogonia. Among E3 ubiquitin ligases, the most abundant transcripts (!700) were those of the Cullin 1 (Cul1), the tripartite motif family members Trim28 (TIF1b; transcriptional intermediary factor 1), the F-Box (FBX) Fbx15, Mdm2, and the RING-type E3 ligase Rnf19. Trim47 (GOA, accession no. RNF100) transcripts were nearly 2-fold higher in gonocytes than in spermatogonia and Sertoli/myoid cells at both ages (Table 4) . Several E3 messengers were more prominent in germ cells than in somatic cells (;2-fold), including Mdm2, Fbxo7, Fbxo33, Rnf134, Rnf149, Rnf139, Rnf138, Rnf125, and Rnf17. Regarding E2 conjugating enzymes, only a few presented high transcript levels, including Ube2e3, Ube2r2, and Arih1, the last being 1.8-fold more prominent in germ cells. Ube2l6 transcript levels were 1.7-fold higher in gonocytes than in spermatogonia and 1.5-fold higher in germ cells than in somatic cells. Among DUB enzymes, the most abundant mRNA was that of the ubiquitin specific protease (Usp) Usp14, present at similar levels in all cell types, followed by Usp3, which was the highest in gonocytes. Usp3, Uchl1 (ubiquitin carboxy-terminal hydrolase L1), Usp2, Usp28, and Usp24, were significantly higher by 1.7 to 4-fold in germ cells. There were only two E1 enzymes with expression signals above 50, Ube1dc1, more abundant in germ cells than Sertoli/ myoid cells, and Ube1c. It should be noted that the most common E1 activating enzymes, UBA1 and UBA6, were not represented on the rat Illumina arrays, similar to several of the genes examined in previous studies, such as Ubc2, Ubc4, and Ubr5. However, the array included several Ube2 genes that were described as homologs of Ubc4/5. Some of the genes presented in Table 4 were further validated by qPCR analysis.
Functional annotation clustering using DAVID Bioinformatics resource version 6.7 software (National Institutes of Health, Bethesda, MD) [40, 41] , revealed that the majority (61) of the 91 genes selected were functionally related to ubiquinmediated proteolysis (Table 5 , clusters 1, 5, and 10). A number of genes belonged to more than one functional cluster, suggesting that they might be involved in several functions, UBIQUITIN SYSTEM IN GONOCYTE DIFFERENTIATION (Fig. 3B , Table 5 ).
Differential Expression of UPS Genes in PND3 Gonocytes and PND8 Spermatogonia
The goal of this analysis was to identify UPS genes that would be preferentially expressed in gonocytes and might be characteristic of the neonatal germ cell and its functions, as well as UPS genes differentially expressed in gonocytes and spermatogonia that would be indicative of differences in the ubiquitin systems of the two developmental phases. This comparative analysis showed that 28 genes presented statistically significant differences in their transcripts levels between gonocytes and spermatogonia, while 38 genes showed significantly higher mRNA levels in germ cells than in somatic cells (Table 4 ). The transcript levels of some of these genes were further quantified by qPCR analysis. In addition to these genes, we also quantified the mRNA levels of genes previously reported to be expressed in spermatogonia, as well as the two main E1 ubiquitin-activating enzymes Uba1 and Uba6 (ubiquitin-like modifier activating enzyme 6; Ube1l2) that were not represented on the Illumina arrays. The primer efficiency was successfully validated for 6 primer sets, including the reference 18S rRNA, Ubb, Ube2i, Huwe1, Ubr5, and Rnf149 genes. However, the qPCR primers of 2 of the genes presenting discrepancies between arrays and qPCR data were found to be suboptimal, explaining the discrepancy found between the two methods. Thus, these genes were not included in the final qPCR results. There was a good agreement between the differential expressions observed in the arrays and by qPCR analysis for most genes.
The expression levels of UPS genes in gonocytes were compared to those in spermatogonia. As shown in Figure 4 , the transcript levels of E1-activating enzymes Uba1 and Uba6 in spermatogonia were only 10% of their values in gonocytes. Similarly, the transcript levels of the E3 ligases Huwe1, Trim47, and Rnf149 were 2-fold higher in gonocytes, in agreement with the gene array data. However, the transcript level of Rnf134 was 2-fold higher and that of Rnf138 was 7-fold higher in spermatogonia. In contrast, most E2 conjugating enzymes were expressed at levels in spermatogonia that were higher than in gonocytes, the largest differences being in Ube2e3, Ube2g1, Ubc4, and Ube2c, which were, respectively, 10-fold, 6-fold, 4-fold, and 3.5-fold higher in spermatogonia than in gonocytes. Among the DUBs, Usp24 was 3-fold higher and Usp25 was 1.8-fold higher in spermatogonia than in gonocytes, presenting the same trend as on gene array, while Uchl1 showed higher levels in spermatogonia by qPCR but not on gene array. The other DUBs measured by qPCR showed expression levels that were comparable between the two cell types, while some of these genes appeared differentially expressed on array. It should be noted that we measured separately the two transcripts of Usp2, Usp2a, corresponding to the mRNA of the long 69-kDa variant, and Usp2b, corresponding to the messenger of the short 45-kDa isoform. The * Genes that were expressed in gonocytes (G3) above a cut-off point set at 50 are shown and compared to their expression levels in spermatogonia (G8) and somatic cells (S3, S8). Values are means 6 SEM. z P , 0.06 are shown, and differences with a P value 0.05 were considered significant.
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data showed that the expression of the short Usp2 transcript was higher than that of the long transcript in spermatogonia. Ubb and Uba52 were more than 4-fold higher in spermatogonia than gonocytes. It should be noted that not all changes observed by qPCR were in agreement with the data obtained by gene array, probably due to the different approaches and sequences targeted in these methods. Overall, these data highlighted the existence of large differences between the UPS mRNA profiles of gonocytes and spermatogonia.
Retinoic Acid Affects Expression of Spermatogonial Markers and UPS Genes Differently in Gonocytes
In view of the differences in UPS gene expression profiles between gonocytes and spermatogonia and our finding that the proteasome activity is required for RA-induced gonocyte differentiation, we further examined whether UPS genes were altered by RA treatment as a way to determine whether UPS remodeling occurred during gonocyte differentiation and to identify genes more specific for gonocytes than later phases of development. As shown in Figure 5 , RA treatment significantly increased the expression of the spermatogonial markers Stra8 by 6-fold and Dazl by 1.7-fold, as well as that of the germ cell markers Vasa and Mili by 1.6-and 1.4-fold, respectively. Simultaneously, the transcript levels of the E1 activating enzymes and half of the E3 ligases examined were not changed, while the E3 ligases Ubr5, Fbxo7, Rnf139, -149, and -10 were significantly decreased upon RA-induced differentiation (Fig. 5) . Among those, Rnf149 was also found to be less abundant in spermatogonia than in gonocytes, suggesting that expression of this UPS gene is decreased during the process of differentiation and remains low thereafter. Most DUBs were decreased by RA treatment, as were all but one E2-conjugating enzyme (Fig. 5) . Taken together with the fact that these enzymes were either unchanged or higher in spermatogonia than gonocytes, these results suggest that RA altered their expression in a transient manner in differentiating gonocytes. Thus, these results indicated that some components of the proteasome system were altered during gonocyte differentiation, whereas others remained constant, and pinpointed Rnf149 as being preferentially expressed in gonocytes.
DISCUSSION
This report shows for the first time that the regulated degradation of proteins via the ubiquitin proteasome system is central to gonocytes differentiation into spermatogonia and provides an extensive profiling of the USP genes expressed during this critical period of germ cell development. The formation of spermatogonial stem cells from neonatal gonocytes provides the foundation from which spermatogenesis will proceed and is essential for male fertility. We hypothesized that the ubiquitin proteasome system participates in the extensive remodeling that takes place in differentiating gonocytes. This hypothesis was validated by our finding that the proteasome inhibitor lactacystin blocked the ability of RA to increase the expression of the differentiating spermatogonia markers Stra8 and Dazl in gonocytes. Stra8 was chosen as an indicator of gonocyte differentiation because of previous studies, including ours, in which RA was found to increase the mRNA expression of Stra8 in isolated gonocytes [22, 35] , and to increase STRA8 protein expression in PND2 gonocytes in organ culture [36] . STRA8 protein was also detected in PND5 mouse gonocytes in vivo [36] , an age at which germ cells are still gonocytes, most of them in the process of migrating toward the basement membrane of the seminiferous cords where they will finalize their differentiation. In search of other germ cell-specific genes potentially altered during gonocyte differentiation, we found that the mRNA expression of Dazl, a gene known to be expressed in differentiating spermatogonia [37] , was increased in RA-treated gonocytes, simultaneously with Stra8, suggesting that Dazl could be used as a marker of gonocyte differentiation. Lactacystin, a nonreversible proteasome inhibitor synthesized by members of the Streptomyces genus, binding the b-1 subunit of the 26S proteasome catalytic core [38, 39] , blocked the ability of RA to induce gonocyte differentiation in vitro, as reflected by its inhibitory effects on Stra8 and Dazl mRNA expression. Similar effects were obtained with bortezomib, a dipeptide boronic acid acting on the same site of the proteasome as lactacystin, but in a reversible manner [39] , confirming the fact that the effects observed were indicative of proteasome inhibition. The   FIG. 3 . Relative proportion of each type of UPS genes expressed in gonocytes and main functional clusters. UPS genes expressed in gonocytes and spermatogonia were identified on gene arrays. Genes expressed at a signal intensity equal to or greater than 50 were selected. A) The proportions represented by each type of enzyme (E1, E2, E3, DUB) and other UPS-related genes were evaluated, showing that more than 50% of the genes expressed in germ cells were E3 ligases. B) Functional annotation clustering of the UPS genes, using DAVID Bioinformatics Resources version 6.7 software (NIH). Although proteasomal degradation was the most common function involving UPS genes in germ cells, other functions were also well represented among the genes expressed in germ cells.
involvement of proteasomal activity in cell differentiation is not unique to gonocytes, as proteosomal degradation was also shown to be required for the differentiation of preadipocytes into adipocytes [42] . Lactacystin was also found to block RAinduced G 1 arrest and differentiation of RA-sensitive breast cancer cells by preventing the RA-induced degradation of a critical scaffolding protein mediating insulin-like growth factor type-I receptor signaling in these cells [43] . In contrast, blocking proteasomal degradation in osteoblasts in vitro and in vivo had the opposite effect on differentiation by preventing the degradation of phosphorylated Smad members [44] . The existence of biological systems in which proteasome activity can either block or support cell differentiation highlights the complexity of the ubiquitin system and the multiplicity of its target proteins [1] [2] [3] [4] . The observation that the mRNA expression of Dazl was reduced by proteasome inhibitors below its basal level suggests that proteasomal degradation is involved either in the regulation of Dazl transcription or the stability of its messenger, and the maintenance of Dazl homeostasis in gonocytes. However, this does not appear to be a common mechanism in gonocytes, since proteasome inhibitors did not have an effect on the basal transcript levels of other genes, including Stra8 and several UPS and housekeeping genes in gonocytes.
FIG. 4.
Differential expression of UPS genes between gonocytes and spermatogonia. Germ cells were isolated from PND3 and PND8 rat testes, their RNA extracted and processed for mRNA quantification by qPCR. The transcript levels of 30 UPS genes were determined. Results are expressed as fold change values over expression levels in gonocytes, and are means 6 SEM of data obtained from 3 to 4 independent preparations, with each sample performed in triplicate. *P , 0.05; **P , 0.01; ***P , 0.001.
UBIQUITIN SYSTEM IN GONOCYTE DIFFERENTIATION
Gene expression profiling identified a large number of UPS transcripts in gonocytes and spermatogonia. Functional annotation of these genes indicated that, besides belonging to gene clusters linked to proteasomal degradation, a number of UPS genes were included in categories related to processes such as transcriptional regulation (negative or positive), protein biogenesis, cell cycle, and histone and chromatin modifications. This suggests that UPS proteins might participate in the regulation of proliferation and gene transcription, directly or via chromatin modifications, in early phases of germ cell development. Indeed, some of the genes highly expressed in gonocytes are well known for their involvement in histone and chromatin remodeling. Among those, the E2 enzyme UBC2 is believed to regulate transcriptional activation by catalyzing the mono-ubiquitination of histones and to be an RA-responsive gene during rat embryo development [45] , two important processes in gonocyte development. The E3 ligase Trim28 (TIF1b), abundant in germ and somatic cells, was also shown to affect chromatin structure [46] and to be a transcriptional corepressor required for proper spermatogenesis [47] . Similarly, HUWE1 (ARF-BP1; LASU1), corresponding to the most abundant E3 ligase transcript in gonocytes, is highly expressed in the nuclei of spermatogonia and spermatocytes and was shown to poly-ubiquitinate histones in vitro [28] and was proposed to play a role in histone removal during chromatin condensation in elongating spermatids [48] . However, the localization of Huwe1 in gonocyte cytoplasm and in cytoplasmic extensions of germ cells making contact with the basement membrane of the seminiferous cords suggest that Huwe1 has a distinct role unrelated to chromatin remodeling at FIG. 5 . Effects of RA on the mRNA expression of differentiation markers and on UPS gene expression levels in isolated gonocytes. Gonocytes were isolated from PND3 rat testes and incubated for 1 day with medium alone or supplemented with 1 lM all-trans RA and further processed for mRNA analysis as described in the legend to Figure 1 . Results are fold change values over expression levels in control gonocytes and are expressed as means 6 SEM of data obtained from 3 independent preparations, with each sample performed in triplicate. *P , 0.05; **P , 0.01; ***P , 0.001.
this stage of germ cell development. Histone deubiquitination via the action of USP3, an abundantly expressed DUB in gonocytes and spermatogonia, may also play a role in chromatin remodeling and genome stability [49] in these cells. The strong expression of these genes in gonocytes is in agreement with the high levels of DNA methylation and chromatine remodeling that take place in neonatal gonocytes as part of the paternal imprinting process [50] .
Among the UPS genes potentially involved in gonocyte and spermatogonia cell cycle is Ubr5 (EDD), the ubiquitin protein ligase E3 component n-recognin 5, previously found to play a role in cell cycle progression and G 2 /M DNA damage checkpoints [51, 52] . It has become evident that some ubiquitin ligases stabilize proteins rather than mark them for degradation. This is the case of Ubr5, which was reported to stabilize bcatenin via its ubiquitination, resulting in the upregulation of the Wnt signaling pathway [53] . Interestingly, both HUWE1 and Ubr5 are HECT-type E3 ligases recently shown to play a role in cell cycle progression by interacting with the tumor suppressor p53 [54] [55] [56] . Moreover, gonocytes and spermatogonia express high levels of Mdm2 transcript, an oncogenic ring finger E3 enzyme that targets p53 for proteosomal degradation [57] . Gene array analysis showed that p53 transcript was present in gonocytes and spermatogonia and their aged-matched Sertoli/myoid cells (data not shown). Thus, neonatal gonocytes and PND8 spermatogonia appear to be equipped with several alternative ways to modulate p53 levels. This might be important for the regulation of the cell cycle and maintenance of germ cell genomic integrity. Our immunohistological studies showed that Ubr5 accumulated at the same subcellular location as HUWE1, inside cytoplasmic extension contacting the basement membrane, together with ubiquitin and the DUB USP2. The colocalization of several members of the UPS cascade at these sites suggests that UPS is involved in the contact formation between germ cells and the basement membrane and the extensive remodeling occurring at this location. These findings could be important clues toward understanding the events that take place upon anchorage of the germ cell to the basement membrane, a requirement for the cell to progress in its differentiation program.
Among the genes identified in the study, only a few were preferentially expressed in germ cells, positioning them as good candidates for being involved in germ cell function at these ages. Despite not being very abundant in terms of mRNA FIG. 6 . Schematic representation of the ubiquitin proteasome system in gonocytes. Ubiquitin is provided from processing of products of polyubiquitin or Uba52 ubiquitin fusion genes or from recycling from ubiquitinated cellular proteins. Ubiquitin is activated by an E1 ubiquitin-activating enzyme in an ATP-dependent manner. Ubiquitin is then transferred to an E2 ubiquitin conjugating enzyme. The E2 enzyme interacts with an E3 ubiquitin ligase carrying the protein substrate to be ubiquitinated, resulting in the transfer of activated ubiquitin to the substrate. Successive conjugation of ubiquitin molecules onto the substrate will lead to the formation of a polyubiquitin chain, acting as a recognition signal for the 26S proteasome that will then degrade the substrate in small peptides and release reusable ubiquitin molecules. Deubiquitinating enzymes (DUBs) can modulate the E1-E3 pathway or stabilize protein substrates by removing ubiquitin moieties from a tagged substrate. As indicated, the UPS can also participate in the regulation of functions not related to proteasomal degradation. Genes highly or preferentially expressed in gonocytes are indicated in italics. 
levels, Rnf17 was the only gene showing much higher mRNA levels in germ cells than in somatic cells, while it was expressed at similar levels in gonocytes and spermatogonia. Rnf17 has been shown to be essential for spermatocyte and spermatid differentiation in studies using a Rnf17 knockout mouse model, which presented male sterility and an arrest in round spermatids [58] . The present findings suggest that Rnf17 also might play a role in earlier phases of germ cell development. Cul1, the most abundant E3 ligase in gonocytes, was also significantly more highly expressed in germ cells than in somatic cells. The covalent binding of Nedd8 onto Cul1 has been shown to increase the ubiquitination activity of the ligase [59] . The finding that Nedd8 is among the most highly expressed UPS gene in gonocytes and spermatogonia suggests that neddylation might be involved in the regulation of the ubiquitination process in these cells. A large number, but still a select minority of genes, showed significant regulation upon transitioning from gonocytes to spermatogonia: E1 enzymes were markedly down-regulated; and E2 enzymes were mainly up-regulated, while E3 ligases showed both up-and down-regulation, indicating that these critical substrate-recognizing proteins must be precisely regulated. A few DUBs were also specifically upregulated, as were ubiquitin-encoding genes , presumably to ensure adequate supply of ubiquitin for spermatogonial proliferation and differentiation. The transcripts of E1 enzymes Uba1 (Uae) and Uba6 were strikingly expressed at higher levels in gonocytes than in spermatogonia. UBA1 was shown to be expressed in adult germ cells and is required for sperm capacitation and fertilization [60] , while UBA6 was reported to play a role in the transition from mitosis to meiosis [61, 62] . Considering that the two enzymes mediate different types of functions despite being coexpressed in some cell types [4, 63, 64] , our finding further support the idea that UPS acts at multiple levels in gonocytes.
Amid the E2 enzymes expressed at high levels in gonocytes and spermatogonia, Ube2e3 appears to be an interesting gene to study further because its silencing in epithelial cells was shown to block cell proliferation, while cell differentiation decreased its expression, suggesting that it plays a role in the balance between proliferation and differentiation [65] . Two other potentially important E2 enzymes are UBC2 and UBC4, both of which were expressed in gonocyte cytosol but appeared to be either cytosolic or nuclear in spermatogonia. In earlier studies, we found that both enzymes were present in rodent testis, in which UBC4 was restricted to spermatids, and that UBC4 deletion led to a delay in spermatogenesis [27, 66] . The present findings showing that UBC2 and UBC4 proteins are also present in gonocyte and spermatogonial suggest that they might also participate to early phases of germ cell development.
Another level of regulation of the ubiquitin system is provided by the existence of deubiquitinating enzymes. USP2 was one of the few DUBs expressed at higher level in gonocytes than in spermatogonia and in germ cell than in somatic cells. We previously showed that the USP2 gene generates two isoforms in testis by using different promoters, resulting in proteins with different N termini and substrate specificities [29] . Interestingly, gonocytes expressed both transcripts at similar levels but a higher level of USP2a protein, whereas spermatogonia presented higher levels of USP2b transcripts, suggesting that the two isoforms were differentially regulated during gonocyte and spermatogonial differentiation. While USP2 protein signal was localized in the cytoplasm of spermatogonia both in situ and in vitro, USP2 appeared to shift from the cytoplasm to the nucleus between UBIQUITIN SYSTEM IN GONOCYTE DIFFERENTIATION gonocytes observed in situ and those isolated from the Sertoli cells for a few hours. This change, which was seen only for USP2, suggests that the subcellular localization of USP2 in gonocytes is regulated by the Sertoli cells. We recently reported that USP2 À/À mice present defects in spermatid development, as well as fertilization-deficient spermatozoa [15] . Together with the present data, this suggests that USP2 might play a role at different periods of germ cell development. Regarding USP19, the germ cell-restricted expression of the protein places it as an interesting candidate gene to study further. Although nothing is yet known of its potential role in testis, USP19 has been shown to regulate the stability of a cyclin-dependent kinase inhibitor involved in the control of G 1 to S phase progression [6] and to play a role in the turnover of endoplasmic-reticulum-associated degradation proteins [67] .
In the present study, we found that the responses to RA in term of UPS gene expression differed from the profiling data between gonocytes and spermatogonia, suggesting that the dynamics of regulation are highly stage-dependent between gonocytes and spermatogonia. RA treatment of gonocytes increased the mRNA expression of Stra8 as expected, as well as the transcript levels of the germ cell markers Dazl, Vasa, and Mili. Vasa is a germ cell-specific RNA helicase that is believed to act as a post-transcriptional regulator [68] , whereas Mili is a piwi-interacting RNA binding protein expressed from gonocytes to early spermatocytes that was shown to be essential for spermatogonial stem cell self-renewal and differentiation [69] . These data demonstrate that isolated gonocytes can recapitulate several aspects of their differentiation process in vitro, further validating the use of this model to study RA-induced gonocyte differentiation. In contrast to its effects on spermatogonial markers, RA decreased the expression of most of UPS genes examined. Our results suggest that most UPS genes are transiently down-regulated during gonocyte differentiation, returning to higher expression levels at later stages of development. The only gene that appeared to be altered in a similar manner during in vitro and in vivo gonocyte differentiation was Rnf149 (also called DNA polymerasetransactivated protein 2; DNAPTP2). RNF149 belongs to the RING-type E3 ligases, a family of E3 ligases characterized by a common RING finger motif composed of a linear series of cysteine and histidine residues, which can bind two zinc atoms [70] . However, nothing is yet known of the role of this protein.
Taken together, the decreased expression of RNF149 in differentiating gonocytes in vitro and its lower level of expression in spermatogonia in comparison to gonocytes, suggest that the downregulation of this gene might be part of the differentiation process.
The importance of the UPS system in spermatogenesis and male fertility is supported by the existence of knockout mouse models in which the absence of a specific UPS gene resulted in the disruption of spermatogenesis. Indeed, several of the genes identified in gonocytes and spermatogonia have been reported to play a role in spermatogenesis. This is the case of Ubb, a polyubiquitin gene producing 3 to 4 ubiquitin repeats, for which gene disruption was shown to prevent spermatogenesis beyond the pachytene stage and to lead to infertility [10] . Another example is USP14, which was shown to be required for spermatogenesis and male fertility in studies using the homozygous ataxia mouse model in which the reduction of Usp14 was found to disrupt spermiogenesis [11] . Our finding that USP14 is the most abundant DUB in gonocytes and spermatogonia suggests that this gene is also important in early germ cell development. Another DUB that stands out from our data are Uchl1, which appeared upregulated in spermatogonia, but transiently decreased during gonocyte differentiation. Uchl1 was originally proposed to play a role in the early apoptotic wave responsible of removing abnormal germ cells during spermatogenesis [71] . However, it was recently shown to be differentially expressed in spermatogonia and proposed to play a role in the maintenance and asymmetrical division of spermatogonial stem cells undergoing differentiation and selfrenewal processes [72] . Our results are in agreement with these data, showing a major role of Uchl1 after the first postnatal week, coinciding with the period at which germ cells that failed to migrate to the basement membrane are eliminated by apoptosis.
In conclusion, this study revealed that the proteasome participates in the process of gonocyte differentiation, suggesting that specific proteins need to be degraded, most likely proteins involved as functional brakes or inhibitors preventing the gonocyte-spermatogonia transition. We also identified novel UPS genes in gonocytes and spermatogonia, many of them never described in testis or germ cells before (Fig. 6) . While some UPS genes were expressed at high levels in both germ cell types and others overexpressed in spermatogonia, several genes showed a noticeably higher expression in gonocytes, suggesting a specific role in gonocyte functions. The exact function of UPS genes in germ cells and the identity of their substrates and interacting proteins remain to be determined. Noticeably, several of the UPS genes identified in gonocytes have been previously associated with functions that are critical for gonocyte development, such as cell cycle progression during mitosis, gap junction remodeling, likely to take place during germ cell migration, endocytosis required for the turnover of cell surface receptors, and DNA remodeling during paternal imprinting and cell differentiation. Thus, the identification of the UPS genes present in gonocytes is only the first step in the understanding of the network of interactions taking place between UPS proteins and their substrates during gonocyte differentiation. The present study will provide a framework on which to design targeted studies that will elucidate the role of UPS and the mechanisms regulating gonocyte development.
